208 related articles for article (PubMed ID: 11584521)
1. [New study of selective COX-2 inhibitors. Protecting the stomach while risking the heart? (interview by Dr. Beate Schumacher)].
Zeidler H
MMW Fortschr Med; 2001 Sep; 143(35-36):14. PubMed ID: 11584521
[No Abstract] [Full Text] [Related]
2. [Gastric protective pain therapy. What is the advantage of new COX-2 inhibitors?].
Hinz B; Brune K
MMW Fortschr Med; 2000 Mar; 142(11):39-40. PubMed ID: 10786088
[No Abstract] [Full Text] [Related]
3. [COX-2 specific inhibitors: are NSAIDs and the stomach become reconcilied?].
Bannwarth B
Gastroenterol Clin Biol; 2001 Apr; 25(4 Suppl):B79-84. PubMed ID: 11449148
[No Abstract] [Full Text] [Related]
4. COX-2 selective non-steroidal anti-inflammatory drugs and cardiovascular disease.
Ray WA; MacDonald TM; Solomon DH; Graham DJ; Avorn J
Pharmacoepidemiol Drug Saf; 2003; 12(1):67-70. PubMed ID: 12616850
[No Abstract] [Full Text] [Related]
5. COX-2 inhibitors: better than traditional NSAIDs? Vioxx and Celebrex may be no less risky than NSAIDs.
Atkinson HG
Health News; 2002 Aug; 8(8):5. PubMed ID: 12206146
[No Abstract] [Full Text] [Related]
6. Arthritis. Should you be taking a COX-2 inhibitor?
Harv Health Lett; 2001 Nov; 27(1):1-3. PubMed ID: 11724695
[No Abstract] [Full Text] [Related]
7. COX-2 inhibitors: no pain, no heart gain?
Harv Heart Lett; 2001 Dec; 12(4):2-4. PubMed ID: 11751079
[No Abstract] [Full Text] [Related]
8. Differences between COX-2-specific inhibitors: clinical and economic implications.
Sonnenblick EH
Am J Manag Care; 2002 Oct; 8(15 Suppl):S428-30. PubMed ID: 12416792
[No Abstract] [Full Text] [Related]
9. The coxibs, selective inhibitors of cyclooxygenase-2.
Killen JP
N Engl J Med; 2001 Dec; 345(23):1708; author reply 1709. PubMed ID: 11759656
[No Abstract] [Full Text] [Related]
10. [Selective COX-2 inhibitor. Stomach protection--but not always].
MMW Fortschr Med; 2001 Jun; 143(25):60. PubMed ID: 11469005
[No Abstract] [Full Text] [Related]
11. COX-2 inhibitors and Celebrex: safe or suspect?
Health News; 1999 Jun; 5(7):4. PubMed ID: 10932776
[No Abstract] [Full Text] [Related]
12. [Safety of selective inhibitors of inducible cyclooxygenase-2 taken for a long period].
Lamarque D
Bull Cancer; 2004 May; 91 Spec No():S117-24. PubMed ID: 15239340
[TBL] [Abstract][Full Text] [Related]
13. Relationship between selective cyclooxygenase-2 inhibitors and acute myocardial infarction in older adults.
Solomon DH; Schneeweiss S; Glynn RJ; Kiyota Y; Levin R; Mogun H; Avorn J
Circulation; 2004 May; 109(17):2068-73. PubMed ID: 15096449
[TBL] [Abstract][Full Text] [Related]
14. Treatment of rheumatoid arthritis and osteoarthritis with COX-2-selective inhibitors: a managed care perspective.
Hochberg MC
Am J Manag Care; 2002 Nov; 8(17 Suppl):S502-17. PubMed ID: 12458820
[TBL] [Abstract][Full Text] [Related]
15. FDA refuses companies' request to drop ulcer warning.
Gottlieb S
BMJ; 2001 Feb; 322(7283):385. PubMed ID: 11179151
[No Abstract] [Full Text] [Related]
16. [Specific inhibitors of cyclooxygenase type 2] ].
Tomasová-Studýnková J
Vnitr Lek; 2002 May; 48(5):403-8. PubMed ID: 12061207
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular events and COX-2 inhibitors.
Fleming M
JAMA; 2001 Dec; 286(22):2808; author reply 2811-2. PubMed ID: 11735742
[No Abstract] [Full Text] [Related]
18. COX-2 inhibitors: new drugs for the management of pain and inflammation.
Hutchins V; Hutchins B
Dent Today; 2001 Feb; 20(2):56-61. PubMed ID: 12524847
[No Abstract] [Full Text] [Related]
19. Cyclooxygenase inhibition: between the devil and the deep blue sea.
Hawkey CJ
Gut; 2002 May; 50 Suppl 3(Suppl 3):III25-30. PubMed ID: 11953329
[TBL] [Abstract][Full Text] [Related]
20. [No loss of effectiveness with rofecoxib. Long-term control of rheumatoid pain].
Einecke D
MMW Fortschr Med; 2002 Nov; 144(46):68. PubMed ID: 12534087
[No Abstract] [Full Text] [Related]
[Next] [New Search]